Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Free Cash Flow: 2020-2024

Historic Free Cash Flow for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$24.1 million.

  • Journey Medical's Free Cash Flow fell 105.96% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 85.89%. This contributed to the annual value of -$24.1 million for FY2024, which is 10152.92% down from last year.
  • Journey Medical's Free Cash Flow amounted to -$24.1 million in FY2024, which was down 10,152.92% from $240,000 recorded in FY2023.
  • Over the past 5 years, Journey Medical's Free Cash Flow peaked at $240,000 during FY2023, and registered a low of -$33.5 million during FY2022.
  • Moreover, its 3-year median value for Free Cash Flow was -$24.1 million (2024), whereas its average is -$19.1 million.
  • Per our database at Business Quant, Journey Medical's Free Cash Flow surged by 100.72% in 2023 and then plummeted by 10,152.92% in 2024.
  • MRY analysis of 5 years shows Journey Medical's Free Cash Flow stood at -$2.7 million in 2020, then rose by 20.40% to -$2.2 million in 2021, then tumbled by 1,437.55% to -$33.5 million in 2022, then surged by 100.72% to $240,000 in 2023, then tumbled by 10,152.92% to -$24.1 million in 2024.
  • Its Free Cash Flow was -$24.1 million in FY2024, compared to $240,000 in FY2023 and -$33.5 million in FY2022.